Please find here the guidance/guidelines from the BSBMTCT Guidelines Sub Committee, other BSBMTCT Sub Committees and BSBMTCT Representative Groups:

UK Consensus on the Use of PTCy

• UK Clinical Community Consensus on the Emerging use of PTCy 2025

UK Recommendation for Chimerism Testing and Monitoring following allogeneic HSCT

• UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation(HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping(UK NEQAS LI) 2025

UK Consensus Statement on the Use of Plerixafor in Healthy Stem Cell Donors

• UK consensus statement on the use of plerixafor in healthy stem cell donors 2025

Practice Guideline: Preparation for CAR-T therapy in children and young adults with B-ALL

• Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia 2024

Joint Consensus Statement on the vaccination of adult and paediatric HSCT recipients

• Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children’s cancer and Leukaemia Group (CCLG), and British Infection Association (BIA) Vaccination consensus statement 2023

UK Best Practice Consensus Guideline: Management of patients with germline predisposition to haematological malignancies considered for allogeneic BMT

• Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Clinical Genetics Group (UKCGG), CanGene-CanVar,NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT) 2023

Workforce Consensus Recommendations for Paediatric HSCT Centres

• Br J Haematol – 2025 – Elfeky – Workforce consensus recommendations for paediatric haematopoietic stem cell transplant

BSBMTCT SARS CoV 2 Vaccination Statement

• BSBMTCT SARS-CoV-2 vaccination statement (Updated 04Apr2024)
• Paediatric BSBMTCT COVID Guidelines Group (Updated 16th May 2022)